Erythropoiesis-stimulating agents (ESAs) and iron supplementation are the backbone of treating anemia in chronic renal disease. Guidelines have evolved with ESA and IV iron use, and many clinics now follow evidence-based protocols. This session reviews anemia evaluation and management, emphasizing interprofessional collaboration to optimize patient outcomes and improve the quality of care for individuals with chronic kidney disease.
Credit & MOC Details
Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.
Credit types
MOC types
FDA REMS
Qualifies for MIPS
Target Specialties
Specialties served/covered
- No reviews yet. Be the first to share yours.
- Article / monograph / reference
- Credit · Up to 1.5 credits
- MOC · Up to 1.5 points
- Paid · fee on provider site
-
ReleasedNov 11, 2025
-
Last day to claim creditNov 13, 2027 1 year left
-
National Kidney Foundation Advancing Anemia Care in Dialysis: Integrating New Evidence and Emerging Therapies
-
National Kidney Foundation Potassium in the Balance: Cardiovascular Risks, Diet, and Novel Interventions in Hyperkalemia Care
-
National Kidney Foundation Vitamin and Mineral Needs: What’s the Literature Say?
